INK Ultra Money Free: BioVaxys insiders bet on the haptenization of cancer and covid

During the last week of October we put the Healthcare sector in the spotlight. On Wednesday, we ventured into the biotech space where BioVaxys (BIOV) insiders are betting big on their firm's novel approach to tackling cancer and COVID-19. Join us as a Canadian Insider or INK Research member as we let the insiders guide us to opportunity this fall.

INK Channels: